Evaluating the Role of Postmastectomy Radiation Therapy Based on Pathological Nodal Response in Clinical Nodal Positive Stage II-III Breast Cancer after Neoadjuvant Chemotherapy: A Multicenter Study of 1963 Cases from China

被引：0
作者：
Huang, Z. [1 ,2 ]
Wang, S. L. [2 ,3 ]
Tang, Y. [2 ,4 ]
Rong, Q. L. [1 ,2 ]
Zhu, L. [5 ]
Huang, X. B. [6 ]
Shi, M. [7 ]
Wang, W. H. [8 ]
Shen, L. [9 ]
Chen, J. Y. [10 ]
Zhang, J. [11 ]
Wu, H. F. [12 ]
Cheng, J. [13 ]
Liu, M. [14 ]
Ma, C. Y. [15 ]
Li, Y. X. [1 ,2 ]
机构：
[1] Chinese Acad Med Sci, Dept Radiat Oncol, Natl Canc Ctr, Canc Hosp, Beijing, Peoples R China
[2] Peking Union Med Coll, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Canc Hosp, Dept Radiat Oncol,Natl Canc Ctr, Beijing, Peoples R China
[4] Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Canc Hosp, Natl Canc Ctr, Beijing, Peoples R China
[5] Tianjin Med Univ Canc Inst & Hosp, Dept Radiat Oncol, Tianjin, Peoples R China
[6] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China
[7] Fourth Mil Med Univ, Xijing Hosp, Dept Radiat Oncol, Xian, Shaanxi, Peoples R China
[8] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing,Dept Radiat Oncol, Beijing, Peoples R China
[9] Cent S Univ, Xiangya Hosp, Dept Oncol, Changsha, Hunan, Peoples R China
[10] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Radiat Oncol, Shanghai, Peoples R China
[11] Hebei Med Univ, Hosp 4, Dept Radiat Oncol, Shijiazhuang, Hebei, Peoples R China
[12] Canc Hosp Jilin Prov, Dept Radiat Oncol, Changchun, Jilin, Peoples R China
[13] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Ctr Canc, Wuhan, Hubei, Peoples R China
[14] Jilin Univ, Hosp 1, Dept Radiat Oncol, Changchun, Jilin, Peoples R China
[15] First Hosp Qiqihaer, Dept Radiat Oncol, Qiqihar, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2019.06.395
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
16
引用
收藏
页码：S8 / S9
页数：2
相关论文
共 50 条
[31]   Neoadjuvant trastuzumab, pertuzumab and tucatinib without chemotherapy in stage II-III HER2-positive breast cancer: The TRAIN-4 study [J].
Louis, F. M. ;
van der Voort, A. ;
Schroder, C. P. ;
Scholten, A. N. ;
Wesseling, J. ;
Peeters, M-J. T. F. D. Vrancken ;
Mann, R. M. ;
Sonke, G. S. .
ANNALS OF ONCOLOGY, 2024, 35 :S347-S347
[32]   Clinical and pathological response after neoadjuvant chemotherapy with or without zoledronic acid for patients with HER2-negative large resectable or stage II or III breast cancer [J].
Charehbili, A. ;
Van de Ven, S. ;
Liefers, G. J. ;
Smit, V. T. ;
Wasser, M. N. ;
Kranenbarg, E. M. Meershoek-Klein ;
Van Leeuwen-Stok, A. E. ;
Van de Velde, C. J. H. ;
Nortier, J. W. R. ;
Kroep, J. R. .
EUROPEAN JOURNAL OF CANCER, 2013, 49 :S401-S401
[33]   Different clinical usefulness of AJCC response criteria according to the subtypes in stage II/III breast cancer patients after neoadjuvant chemotherapy [J].
Yang, Yaewon ;
Im, Seock-Ah ;
Kim, Tae-Yong ;
Lee, Kyung-Hun ;
Keam, Bhumsuk ;
han, Sae-Won ;
Oh, Do-Youn ;
Kim, Tae-You ;
Han, Wonshik ;
Moon, Hyeong-Gon ;
Park, In Ae ;
Noh, Dong-Young .
CANCER RESEARCH, 2015, 75
[34]   The Role of Postmastectomy Radiation Therapy in Clinical T1-3N1M0 Breast Cancer Patients With Pathological Negative Lymph Nodes After Neoadjuvant Chemotherapy and Mastectomy [J].
Rong, Q. L. ;
Wang, S. L. ;
Tang, Y. ;
Jin, J. ;
Song, Y. W. ;
Wang, W. H. ;
Liu, Y. ;
Fang, H. ;
Ren, H. ;
Liu, X. F. ;
Yu, Z. H. ;
Li, Y. X. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02) :E44-E44
[35]   An Integrative Clinical Model for the Prediction of Pathological Complete Response in Patients with Operable Stage II and Stage III Triple-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy [J].
Chung, Wai-Shan ;
Chen, Shin-Cheh ;
Ko, Tai-Ming ;
Lin, Yung-Chang ;
Lin, Sheng-Hsuan ;
Lo, Yung-Feng ;
Tseng, Shu-Chi ;
Yu, Chi-Chang .
CANCERS, 2022, 14 (17)
[36]   Elastography-based AI model can predict axillary status after neoadjuvant chemotherapy in breast cancer with nodal involvement: a prospective, multicenter, diagnostic study [J].
Huang, Jia-Xin ;
Lu, Yao ;
Tan, Yu-Ting ;
Liu, Feng-Tao ;
Li, Yi-Liang ;
Wang, Xue-Yan ;
Huang, Jia-Hui ;
Lin, Shi-Yang ;
Huang, Gui-Ling ;
Zhang, Yu-Ting ;
Pei, Xiao-Qing .
INTERNATIONAL JOURNAL OF SURGERY, 2025, 111 (01) :221-229
[37]   Is elective nodal irradiation beneficial in patients with pathologically negative lymph nodes after neoadjuvant chemotherapy and breast-conserving surgery for clinical stage II–III breast cancer? A multicentre retrospective study (KROG 12-05) [J].
J M Noh ;
W Park ;
C-O Suh ;
K C Keum ;
Y B Kim ;
K H Shin ;
K Kim ;
E K Chie ;
S W Ha ;
S S Kim ;
S D Ahn ;
H S Shin ;
J H Kim ;
H-S Lee ;
N K Lee ;
S J Huh ;
D H Choi .
British Journal of Cancer, 2014, 110 :1420-1426
[38]   Prognosis of Micrometastases Compared to Complete Nodal Response and Macrometastases in cN plus Breast Cancer Patients After Neoadjuvant Chemotherapy: A Population-Based Study [J].
van Nijnatten, T. ;
Moossdorff, M. ;
De Munck, L. ;
Goorts, B. ;
Keymeulen, K. ;
Beets-Tan, R. ;
Lobbes, M. ;
Smidt, M. .
ANNALS OF SURGICAL ONCOLOGY, 2016, 23 :S66-S66
[39]   Deep learning-based predictive model for pathological complete response to neoadjuvant chemotherapy in breast cancer from biopsy pathological images: a multicenter study [J].
Zeng, Huancheng ;
Qiu, Siqi ;
Zhuang, Shuxin ;
Wei, Xiaolong ;
Wu, Jundong ;
Zhang, Ranze ;
Chen, Kai ;
Wu, Zhiyong ;
Zhuang, Zhemin .
FRONTIERS IN PHYSIOLOGY, 2024, 15
[40]   Long-term outcome for neoadjuvant versus adjuvant chemotherapy in early breast cancer and the prognostic impact of nodal therapy response: A population-based study [J].
Liu, Xingrong ;
Bergman, Louise Eriksson ;
Boman, Caroline ;
Foukakis, Theodoros ;
Matikas, Alexios .
EJSO, 2025, 51 (03)
12345